These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 24246527)
1. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease. Barodka VM; Nagababu E; Mohanty JG; Nyhan D; Berkowitz DE; Rifkind JM; Strouse JJ Blood Cells Mol Dis; 2014 Apr; 52(4):230-5. PubMed ID: 24246527 [TBL] [Abstract][Full Text] [Related]
2. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability. Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710 [TBL] [Abstract][Full Text] [Related]
3. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents. Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of increased deformability of deoxygenated sickle cells upon oxygenation. Huang Z; Hearne L; Irby CE; King SB; Ballas SK; Kim-Shapiro DB Biophys J; 2003 Oct; 85(4):2374-83. PubMed ID: 14507701 [TBL] [Abstract][Full Text] [Related]
5. The clinical pathophysiology of sickle cell disease. Embury SH Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018 [TBL] [Abstract][Full Text] [Related]
6. Influence of sickle hemoglobin polymerization and membrane properties on deformability of sickle erythrocytes in the microcirculation. Dong C; Chadwick RS; Schechter AN Biophys J; 1992 Sep; 63(3):774-83. PubMed ID: 1420913 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease. Noomuna P; Risinger M; Zhou S; Seu K; Man Y; An R; Sheik DA; Wan J; Little JA; Gurkan UA; Turrini FM; Kalfa T; Low PS Br J Haematol; 2020 Aug; 190(4):599-609. PubMed ID: 32346864 [TBL] [Abstract][Full Text] [Related]
18. Established and experimental treatments for sickle cell disease. De Franceschi L; Corrocher R Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275 [TBL] [Abstract][Full Text] [Related]
19. A study of erythrocyte deformability in sickle cell disease. Reid HL; Obi GO Trop Geogr Med; 1982 Mar; 34(1):43-6. PubMed ID: 7080186 [TBL] [Abstract][Full Text] [Related]
20. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia. Noguchi CT; Schechter AN Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]